A study of a vaginal ring for the prevention of HIV came back with mixed results. The ring, which delivers two drugs, was safe for 28 days, but only one of the antiretroviral drugs was effective in protecting against the virus.
Teva Pharmaceutical Industries launched its Adasuve inhaled powder for the treatment of agitation associated with schizophrenia and bipolar I disorder in the U.S. The drug is the first of its kind with this delivery system, which uses Alexza Pharmaceuticals' Staccato device for absorption in the lungs.
AstraZeneca won U.S. approval of its Bydureon pen for once-weekly treatment of Type 2 diabetes. The pen will be the first of its kind to hit the market. The prefilled, single-use pen injector delivers microspheres that house exenatide, which is slowly released for better glycemic control.
Texas oral drug delivery specialist Neos Therapeutics pulled in $15.5 million in a Series C round of financing to help propel its line of ADHD controlled-release treatments to the market.
Research in drug delivery is shifting further and further to the nano scale, and while nanotechnology still hovers for the most part just short of the clinical stage, new techniques in manufacturing the particles are crucial to bringing them to the next step.
A research team published in Nature's open-access journal Scientific Reports a proof-of-concept study for a drug delivery system using a tattoo to treat cutaneous leishmaniasis, a potentially deadly skin disease spread by bites from sandflies.
To tackle difficult-to-treat drug-resistant ovarian cancer, researchers at Tel Aviv University have developed nanoparticles designed to accumulate in clusters in tumors to deliver chemotherapy, increasing efficacy and reducing side effects.
A new miniaturized wearable device has shown potential in the delivery of drugs to the inner ear that could someday treat hearing loss in a less invasive way than via constant injection.
Iontophoresis--the use of electric current to deliver drugs and diagnostics--has come back under the FDA's radar as the authorities look at whether restrictions for the decades-old technique should be eased as technology advances.
European regulatory authorities gave Teva a positive opinion for its DuoResp Spiromax inhalation powder, designed to treat asthma and chronic obstructive pulmonary disease. With the recommendation from the Committee for Medicinal Products for Human Use, Teva hopes to have final approval within a few months.
A team of researchers has developed microparticles capable of carrying three different molecules on three different docks, or "patches." They could eventually provide a one-two-three punch against cancer, the researchers say.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a light-activated delivery system for chemotherapy.
To regenerate tissue such as cartilage in the body using stem cells, researchers at Duke University have created a system using a scaffold to deliver gene therapy with built-in growth factors that allow for a programmed regenerative response.
Alternatives means of delivering drugs such as paclitaxel could have a similar effect to drug-eluting stents without the invasive procedure, according to a new study to be published in the journal Nanomedicine: Nanotechnology, Biology and Medicine.
3M Drug Delivery Systems has joined forces with the Delaware outfit Invion to develop inhaled drugs for inflammatory airway diseases.
Using one of nature's simplest structures--the diamond--researchers at UCLA have developed a nanogel that can be embedded into contact lenses, with the ultimate goal of delivering glaucoma drugs to the eye over an extended period of time.
Researchers in China published an article in the journal Biomedical Materials demonstrating the drug-delivery potential of new gold nanoshells for cancer that also use hyperthermic effects to bring toxic cancer drugs to tumors with fewer side effects.
Durect suffered a regulatory setback with the FDA rejection of its Posidur treatment for postoperative pain.
Researchers have shown in early tests that a nasal vaccine for West Nile virus is effective in mice after two doses as opposed to the traditional three for other vaccines. Currently, no vaccine for the disease is available for humans, despite its recent spread in the U.S. and Canada.
Scientists from Alnylam teamed with MIT researchers to develop a new nanoparticle platform with which to better deliver the genetic material to the liver. With MIT professor Robert Langer as one of its authors, the team published a paper in the journal Proceedings of the National Academy of Sciences highlighting its particles, which are inspired by the vehicles the body uses to transport cholesterol.